Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BofA Securities raised its rating on Tandem Diabetes Care to Neutral from Underperform and doubled its price target to $30, citing a shift into the pharmacy channel and a move toward a pay-as-you-go revenue model that could materially improve profitability. Baird separately upgraded the stock to Outperform and also set a $30 target, pointing to the…
LyondellBasell said it will cut its first-quarter dividend to 69 cents per share, citing one of the longest downturns in the chemicals industry. The company said it returned about $2 billion to shareholders in 2025 from existing cash and operations and reiterated a commitment to return 70% of free cash flow through the cycle while prioritizing safe…
LyondellBasell Industries said it will reduce its quarterly dividend from $1.37 to $0.69 per share, a 49.6 percent cut that trims the annual payout to $2.76. The dividend will be paid on March 9 to holders of record on March 2, with an ex-dividend date of Feb. 27. Management and analysts cited strained cash flows, the broader chemicals downturn and…
Blue Owl (OWL) has been hammered by redemptions, lawsuits and distribution uncertainty. The stock trades near its 52-week low with RSI around 30, heavy short interest and an attractive headline yield. We think the worst of headline-driven selling is largely priced in and propose a defined-risk long targeting a recovery to the mid-teens over a 180-t…
Turkish authorities have detained Deutsche Welle correspondent Alican Uludag in Ankara on charges of "disseminating misleading information" and "insulting the president," authorities said. The Istanbul Chief Public Prosecutor’s Office opened a criminal probe citing social media posts and said Uludag will be brought before prosecutors. Deutsche Well…
U.S. stock futures rose modestly in premarket trading as investors took a cautious stance ahead of important inflation and growth reports, while individual equities moved on company-specific news. Chipmaker Nvidia dipped slightly, several Chinese ADRs declined after a Pentagon list reference, and a range of other stocks reacted to earnings, guidanc…
Bitcoin's network, capped supply, and ongoing institutional adoption make the zero-case implausible. This trade idea lays out a clear entry at $45,000, stop at $36,000 and a $70,000 target over a 180 trading day horizon, with catalysts, valuation framing and balanced risks.
Needham has reaffirmed a Buy rating and a $40.00 price target on Five9 following fourth-quarter results that showed reaccelerating subscription revenue growth, stronger AI-related bookings and an uptick in enterprise AI revenue. The quarter included leadership changes, a strategic cloud partnership expansion, and mixed responses from other brokerag…
Cantor Fitzgerald has begun coverage of Satellogic Inc. (SATL) with an overweight rating and a $7.00 12-month price target, signaling substantial upside from the current share price. The research note highlights the company's cost advantage and underutilized capacity, alongside recent contract renewals and capital raises that support near-term oper…
Several firms planning U.S. initial public offerings in 2026 have reduced deal sizes, postponed launches or withdrawn listings as market swings and intensified valuation scrutiny weigh on the pipeline. Notable cases include Clear Street, Agibank and Liftoff Mobile. Analysts see higher IPO volume this year but warn that recent selloffs, particularly…
Bank of America has increased its year-end targets for Japan’s key equity indices, citing stronger-than-expected third-quarter corporate results and a macro-political backdrop that supports further gains. The bank now forecasts TOPIX at 4,100 and the Nikkei 225 at 61,000 by year-end, while signaling expectations for additional guidance upgrades and…
The European Union should be ready to implement its free trade agreement with the Mercosur bloc in the coming months, EU trade chief Maros Sefcovic said, even as France leads domestic opposition and the European Parliament has lodged a legal challenge that could delay ratification. The accord, signed in January after 25 years of talks, would elimin…
BofA Securities upgraded Neptune Insurance Holdings (NYSE: NP) to Neutral from Underperform and nudged its price target up to $23, citing the insurer's revised revenue guidance. The new target, derived from a discounted cash flow model, implies roughly 11% upside from the current trading level. Analysts and other banks have recently revised ratings…
Oppenheimer raised its price target on Deere & Company to $715 from $531 and maintained an Outperform rating, citing robust construction demand, a stabilizing agricultural backdrop, and a move from negative to positive earnings revisions. The stock jumped on the news as Deere reported a significant quarterly earnings and revenue beat.
Oppenheimer increased its price target on Pulse Biosciences (PLSE) to $30 from $22 and kept an Outperform rating, citing recent commercial updates and fourth-quarter results. Pulse reported Q4 2025 revenue of $0.3 million, aligned with Oppenheimer’s estimate, while operating losses continued as operating expenses reached about $18.3 million. The co…
Britain's foreign secretary will hold talks in Washington with the U.S. Secretary of State amid a renewed flare-up over the sovereignty of the Chagos Islands and the continued operation of the joint U.S.-UK base on Diego Garcia. The dispute follows a sovereignty transfer agreed by London last year and a string of contradictory comments from the U.S…
UBS strategists identify tentative recovery signals in the UK equity market driven by improvements in banks and consumer goods. Despite recent outperformance from large caps and a rebound in the FTSE 250, UBS warns the market is an "optional" destination for global capital and recommends stock selection focused on buybacks, dividends and underowned…
Evercore ISI reduced its price target on Five9, Inc. (NASDAQ: FIVN) to $24 from $40 while keeping an Outperform rating following the company’s fourth-quarter results and updated forward guidance. Revenue growth for the quarter was 7.8% year-over-year, with management outlining 2026 and initial 2027 growth expectations that were slightly below prior…
Morgan Stanley lowered LatAm Airlines Group's rating to Equalweight from Overweight while simultaneously raising its price target to $67 from $56. Analyst Jens Spiess pointed to the stock's strong recent performance - including an 85% gain over the past year and a 31% rise in the last six months - as the rationale for taking profits and reassessing…
U.S. stock index futures were largely unchanged on Friday as traders awaited a slate of economic releases - including preliminary fourth-quarter GDP and the Personal Consumption Expenditures index - that could shape expectations for monetary policy easing. Market participants also monitored tensions between Washington and Tehran, a potential U.S. S…
Morgan Stanley identifies the persistence of trade-driven volatility as the central question for U.S. growth in 2026. Analyst Michael Gapen argues that large swings in net trade were a defining feature of 2025 and that if those swings have abated, GDP will provide a clearer reading next year. The bank flags specific import categories - computers, p…
Futures tied to Canada’s primary stock gauge rose on Friday after the S&P/TSX composite recorded a fresh record close. Strength in gold and energy underpinned gains in materials and energy sectors, while traders awaited key U.S. data on inflation and GDP and monitored strains in private credit markets.
William Blair initiated coverage of Zimmer Biomet (ZBH) with a Market Perform rating, citing revenue momentum and a strong gross margin but signaling caution around a planned U.S. commercial reorganization and its potential impact on 2026 forecasts. The stock trades at a P/E of 28 and a market capitalization of $19.67 billion.
Barclays has begun coverage of Amgen Inc. with an Equalweight rating and a $185 price target. While the firm cites solid fiscal 2026 guidance and expected momentum for Repatha after VESALIUS, analyst Carter Gould warned that the Phase 3 MARITIME trial readout is far off, leaving important questions unresolved. Market observers show divergent views …
William Blair launched coverage of Stryker Corporation (NYSE: SYK) with an Outperform rating, pointing to the medical technology company's diversified product mix, recent acquisitions and margin profile. The firm highlighted Stryker's expansion into new clinical areas and data-driven offerings, while noting international expansion and ambulatory su…
